|
Aug 20
|
Even after rising 10% this past week, CollPlant Biotechnologies (NASDAQ:CLGN) shareholders are still down 71% over the past three years
|
|
Aug 20
|
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
|
|
Aug 19
|
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
|
|
Jul 29
|
CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report
|
|
May 16
|
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
|
|
Apr 23
|
CollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its Business
|
|
Apr 4
|
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
|
|
Mar 26
|
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
|
|
Mar 13
|
Shareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years ago
|
|
Jan 2
|
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
|
|
Nov 29
|
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
|
|
Nov 9
|
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
|
|
Nov 3
|
Will CollPlant Biotechnologies (NASDAQ:CLGN) Spend Its Cash Wisely?
|
|
Sep 5
|
CollPlant to Present at the H.C. Wainwright Annual Growth Conference
|
|
Aug 27
|
Results: CollPlant Biotechnologies Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
|
|
Aug 24
|
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
|